A case of pediatric PTLD following autologous stem cell transplantation and review of the literature.

Eckrich MJ, Frangoul H, Knight J, Mosse C, Domm J
Pediatr Transplant. 2012 16 (1): E15-8

PMID: 20819185 · DOI:10.1111/j.1399-3046.2010.01382.x

The development of PTLD is a rare severe adverse event following ASCT. We report on a child with DS who developed PTLD following autologous transplant for relapsed Hodgkin's disease. He was successfully treated with cyclophosphamide, prednisone and rituximab. We also present a comprehensive review of the literature of PTLD in pediatric patients following ASCT.

© 2010 John Wiley & Sons A/S.

MeSH Terms (15)

Antibodies, Monoclonal, Murine-Derived Child Child, Preschool Female Humans Immune System Immunosuppression Lymphoma, Large B-Cell, Diffuse Lymphoproliferative Disorders Male Postoperative Complications Remission Induction Rituximab Stem Cell Transplantation Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: